Health Andrew Joseph If Roe is overturned, the ripples could affect IVF and genetic testing of embryos, experts warn
Politics Nicholas Florko The FDA says it’s in the dark about thousands of dietary supplement ingredients
Politics Lev Facher Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?
First Opinion Ge Bai and David A. Hyman Tax exemptions for nonprofit hospitals: It’s time taxpayers get their money’s worth
Exclusive Rachel Cohrs The Trump administration quietly spent billions in hospital funds on Operation Warp Speed
Politics Mark Sherman — Associated Press Supreme Court overturns Roe v. Wade; states can ban abortion
Insurance Bob Herman Supreme Court rules in favor of insurance plan that pushed kidney failure patient to Medicare
Politics Rachel Cohrs Romney accuses White House of ‘patently false’ information about Covid-19 funds
Health Lev Facher ‘Lives could be at stake’: CDC’s Walensky warns of dire stakes surrounding abortion access
Exclusive Lev Facher Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence
First Opinion Richard J. Baron and Ezekiel J. Emanuel Politicians should not be deciding what constitutes good medicine
Pharmalot Ed Silverman Judge bars Shkreli from running another public company, fines him $1.4 million
Politics Lev Facher Following Lander’s resignation, here’s who might be in line for White House science adviser
Politics Rachel Cohrs Hospital, physician lobbies sue Biden administration over surprise billing regulation
Politics Nicholas Florko Moderate Democrats are still seeking changes to the party’s drug pricing package
First Opinion Stephen Asiimwe, Edith Nakku-Joloba and Aggrey Semeere Isolated in Uganda: How Covid-19 evacuations highlight unfairness of global health partnerships
Exclusive Rachel Cohrs How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal
First Opinion Natalie Ma My company is developing new antibiotics. My resistant infection showed me we need them now
Exclusive Rachel Cohrs and Nicholas Florko Key Senate committee considers a carveout for small biotech companies in drug pricing reforms
Politics Rachel Cohrs Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?
Politics Rachel Cohrs and Lev Facher In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices